Compare CCSI & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCSI | MDXG |
|---|---|---|
| Founded | 2021 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 493.6M | 530.2M |
| IPO Year | 2022 | 2007 |
| Metric | CCSI | MDXG |
|---|---|---|
| Price | $34.85 | $3.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $37.50 | $9.00 |
| AVG Volume (30 Days) | 152.9K | ★ 1.1M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | ★ 1.30 | N/A |
| Revenue | $349,696,000.00 | ★ $418,630,000.00 |
| Revenue This Year | $3.33 | N/A |
| Revenue Next Year | $2.70 | $13.02 |
| P/E Ratio | $26.66 | ★ N/A |
| Revenue Growth | N/A | ★ 19.99 |
| 52 Week Low | $19.42 | $3.03 |
| 52 Week High | $37.30 | $7.99 |
| Indicator | CCSI | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 64.62 | 52.64 |
| Support Level | $25.76 | $3.47 |
| Resistance Level | $36.73 | $3.84 |
| Average True Range (ATR) | 1.84 | 0.13 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 78.60 | 56.25 |
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in the fax cloud business. The company's offerings include communication, data extraction, and digital signature solutions that enable users to securely access, exchange, and manage information across organizational and geographic boundaries. It serves multiple industry verticals, including healthcare, government, financial services, legal, and education. Geographically, the company operates in the United States, Canada, Ireland, and other countries. It derives the maximum revenue from the United States.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.